Literature DB >> 21685370

Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury.

Aparna Krishnamoorthy1, Amrendra Kumar Ajay, Dana Hoffmann, Tae-Min Kim, Victoria Ramirez, Gabriela Campanholle, Norma A Bobadilla, Sushrut S Waikar, Vishal S Vaidya.   

Abstract

Ischemia/reperfusion (I/R) injury in the kidney is a major cause of acute kidney injury (AKI) in humans and is associated with significantly high mortality. To identify genes that modulate kidney injury and repair, we conducted genome-wide expression analysis in the rat kidneys after I/R and found that the mRNA levels of fibrinogen (Fg)α, Fgβ, and Fgγ chains significantly increase in the kidney and remain elevated throughout the regeneration process. Cellular characterization of Fgα and Fgγ chain immunoreactive proteins shows a predominant expression in renal tubular cells and the localization of immunoreactive Fgβ chain protein is primarily in the renal interstitium in healthy and regenerating kidney. We also show that urinary excretion of Fg is massively increased after kidney damage and is capable of distinguishing human patients with acute or chronic kidney injury (n = 25) from healthy volunteers (n = 25) with high sensitivity and specificity (area under the receiver operating characteristic of 0.98). Furthermore, we demonstrate that Fgβ-derived Bβ(15-42) peptide administration protects mice from I/R-induced kidney injury by aiding in epithelial cell proliferation and tissue repair. Given that kidney regeneration is a major determinant of outcome for patients with kidney damage, these results provide new opportunities for the use of Fg in diagnosis, prevention, and therapeutic interventions in kidney disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685370      PMCID: PMC3158721          DOI: 10.1182/blood-2011-02-338061

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease.

Authors:  Lynda A Szczech; William Harmon; Thomas H Hostetter; Paul E Klotman; Neil R Powe; John R Sedor; Paul Smedberg; Jonathan Himmelfarb
Journal:  J Am Soc Nephrol       Date:  2009-02-25       Impact factor: 10.121

Review 2.  Fibrinogen signal transduction in the nervous system.

Authors:  J K Ryu; D Davalos; K Akassoglou
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

3.  Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.

Authors:  Dan Atar; Peter Petzelbauer; Jürg Schwitter; Kurt Huber; Benno Rensing; Jaroslaw D Kasprzak; Christian Butter; Lars Grip; Peter R Hansen; Tim Süselbeck; Peter M Clemmensen; Marcos Marin-Galiano; Bernard Geudelin; Peter T Buser
Journal:  J Am Coll Cardiol       Date:  2009-02-24       Impact factor: 24.094

4.  A rapid urine test for early detection of kidney injury.

Authors:  Vishal S Vaidya; Glen M Ford; Sushrut S Waikar; Yizhuo Wang; Matthew B Clement; Victoria Ramirez; Warren E Glaab; Sean P Troth; Frank D Sistare; Walter C Prozialeck; Joshua R Edwards; Norma A Bobadilla; Stephen C Mefferd; Joseph V Bonventre
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

5.  Fibrinogen binding to ICAM-1 promotes EGFR-dependent mucin production in human airway epithelial cells.

Authors:  Suil Kim; Jay A Nadel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-08       Impact factor: 5.464

Review 6.  Angiogenesis in the kidney: a new therapeutic target?

Authors:  Lilach O Lerman; Alejandro R Chade
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-03       Impact factor: 2.894

Review 7.  Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis.

Authors:  R A Adams; C Schachtrup; D Davalos; I Tsigelny; K Akassoglou
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

8.  Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.

Authors:  Anette Lykke Petri; Anja Hviid Simonsen; Tai-Tung Yip; Estrid Hogdall; Eric T Fung; Lene Lundvall; Claus Hogdall
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

9.  Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor.

Authors:  Christian Schachtrup; Paul Lu; Leonard L Jones; Jae K Lee; Jerry Lu; Ben D Sachs; Binhai Zheng; Katerina Akassoglou
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

10.  Peptide Bbeta(15-42) preserves endothelial barrier function in shock.

Authors:  Marion Gröger; Waltraud Pasteiner; George Ignatyev; Ulrich Matt; Sylvia Knapp; Alena Atrasheuskaya; Eugenij Bukin; Peter Friedl; Daniela Zinkl; Renate Hofer-Warbinek; Kai Zacharowski; Peter Petzelbauer; Sonja Reingruber
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

View more
  24 in total

1.  Fibrin-VLDL Receptor-Dependent Pathway Promotes Leukocyte Transmigration by Inhibiting Src Kinase Fyn and is a Target for Fibrin β15-42 Peptide.

Authors:  Sergiy Yakovlev; Chunzhang Cao; Rebeca Galisteo; Li Zhang; Dudley K Strickland; Leonid Medved
Journal:  Thromb Haemost       Date:  2019-08-29       Impact factor: 5.249

2.  Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury.

Authors:  Dana Hoffmann; Vanesa Bijol; Aparna Krishnamoorthy; Victoria R Gonzalez; Gyorgy Frendl; Qin Zhang; Peter L Goering; Ronald P Brown; Sushrut S Waikar; Vishal S Vaidya
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

3.  Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat.

Authors:  Rodney Rouse; Justyna Siwy; William Mullen; Harald Mischak; Jochen Metzger; Joseph Hanig
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 4.  Mouse model of ischemic acute kidney injury: technical notes and tricks.

Authors:  Qingqing Wei; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2012-09-19

5.  A bioinformatics approach identifies signal transducer and activator of transcription-3 and checkpoint kinase 1 as upstream regulators of kidney injury molecule-1 after kidney injury.

Authors:  Amrendra Kumar Ajay; Tae-Min Kim; Victoria Ramirez-Gonzalez; Peter J Park; David A Frank; Vishal S Vaidya
Journal:  J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 10.121

6.  Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.

Authors:  Qin Zhang; Kelly J Davis; Dana Hoffmann; Vishal S Vaidya; Ronald P Brown; Peter L Goering
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 7.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

Review 8.  The current status of biomarkers for predicting toxicity.

Authors:  Sarah Campion; Jiri Aubrecht; Kim Boekelheide; David W Brewster; Vishal S Vaidya; Linnea Anderson; Deborah Burt; Edward Dere; Kathleen Hwang; Sara Pacheco; Janani Saikumar; Shelli Schomaker; Mark Sigman; Federico Goodsaid
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-08-21       Impact factor: 4.481

Review 9.  Defining the acute kidney injury and repair transcriptome.

Authors:  Sanjeev Kumar; Jing Liu; Andrew P McMahon
Journal:  Semin Nephrol       Date:  2014-06-13       Impact factor: 5.299

10.  MicroRNA-155 deficient mice experience heightened kidney toxicity when dosed with cisplatin.

Authors:  Kathryn L Pellegrini; Tao Han; Vanesa Bijol; Janani Saikumar; Florin L Craciun; William W Chen; James C Fuscoe; Vishal S Vaidya
Journal:  Toxicol Sci       Date:  2014-07-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.